Effect of SMURF2 Targeting on Susceptibility to MEK Inhibitors in Melanoma
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of SMURF2 Targeting on Susceptibility to MEK Inhibitors in Melanoma
Authors
Keywords
-
Journal
JNCI-Journal of the National Cancer Institute
Volume 105, Issue 1, Pages 33-46
Publisher
Oxford University Press (OUP)
Online
2012-12-18
DOI
10.1093/jnci/djs471
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Smurf2 Regulates the Senescence Response and Suppresses Tumorigenesis in Mice
- (2012) C. Ramkumar et al. CANCER RESEARCH
- A tumor suppressor function of Smurf2 associated with controlling chromatin landscape and genome stability through RNF20
- (2012) Michael Blank et al. NATURE MEDICINE
- USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma
- (2012) Pieter J A Eichhorn et al. NATURE MEDICINE
- Phase II, Open-Label, Randomized Trial of the MEK1/2 Inhibitor Selumetinib as Monotherapy versus Temozolomide in Patients with Advanced Melanoma
- (2011) J. M. Kirkwood et al. CLINICAL CANCER RESEARCH
- Ablation of Smurf2 reveals an inhibition in TGF-β signalling through multiple mono-ubiquitination of Smad3
- (2011) Liu-Ya Tang et al. EMBO JOURNAL
- Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
- (2011) Nikhil Wagle et al. JOURNAL OF CLINICAL ONCOLOGY
- In melanoma, beta-catenin is a suppressor of invasion
- (2011) I Arozarena et al. ONCOGENE
- BRAF as therapeutic target in melanoma
- (2010) Claudia Wellbrock et al. BIOCHEMICAL PHARMACOLOGY
- Guidelines for the welfare and use of animals in cancer research
- (2010) P Workman et al. BRITISH JOURNAL OF CANCER
- Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K
- (2010) Jessie Villanueva et al. CANCER CELL
- Pharmacokinetics and pharmacodynamics of AZD6244 (ARRY-142886) in tumor-bearing nude mice
- (2010) Cathrine L. Denton et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Basal and Treatment-Induced Activation of AKT Mediates Resistance to Cell Death by AZD6244 (ARRY-142886) in Braf-Mutant Human Cutaneous Melanoma Cells
- (2010) Y. N. V. Gopal et al. CANCER RESEARCH
- Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
- (2010) Sonja J. Heidorn et al. CELL
- Will the Ubiquitin System Furnish as Many Drug Targets as Protein Kinases?
- (2010) Philip Cohen et al. CELL
- Akt inhibitors in clinical development for the treatment of cancer
- (2010) Sumanta Kumar Pal et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
- (2010) Georgia Hatzivassiliou et al. NATURE
- COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
- (2010) Cory M. Johannessen et al. NATURE
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
- (2010) Ramin Nazarian et al. NATURE
- BRAF Gene Amplification Can Promote Acquired Resistance to MEK Inhibitors in Cancer Cells Harboring the BRAF V600E Mutation
- (2010) R. B. Corcoran et al. Science Signaling
- Mitogen-Activated Protein Kinase Inhibition Induces Translocation of Bmf to Promote Apoptosis in Melanoma
- (2009) M. W. VanBrocklin et al. CANCER RESEARCH
- Smad Ubiquitination Regulatory Factor 2 Promotes Metastasis of Breast Cancer Cells by Enhancing Migration and Invasiveness
- (2009) C. Jin et al. CANCER RESEARCH
- Regulation of Planar Cell Polarity by Smurf Ubiquitin Ligases
- (2009) Masahiro Narimatsu et al. CELL
- Final Version of 2009 AJCC Melanoma Staging and Classification
- (2009) Charles M. Balch et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting the phosphoinositide 3-kinase pathway in cancer
- (2009) Pixu Liu et al. NATURE REVIEWS DRUG DISCOVERY
- MEK1 mutations confer resistance to MEK and B-RAF inhibition
- (2009) C. M. Emery et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Microphthalmia-Associated Transcription Factor Is a Critical Transcriptional Regulator of Melanoma Inhibitor of Apoptosis in Melanomas
- (2008) J. N. Dynek et al. CANCER RESEARCH
- Regulation of TGF-β family signaling by E3 ubiquitin ligases
- (2008) Yasumichi Inoue et al. CANCER SCIENCE
- TGFβ in Cancer
- (2008) Joan Massagué CELL
- The Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase Inhibitor AZD6244 (ARRY-142886) Induces Growth Arrest in Melanoma Cells and Tumor Regression When Combined with Docetaxel
- (2008) N. K. Haass et al. CLINICAL CANCER RESEARCH
- Smurf2 Induces Ubiquitin-dependent Degradation of Smurf1 to Prevent Migration of Breast Cancer Cells
- (2008) Erina Fukunaga et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimetic
- (2008) Mark S. Cragg et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral, Small-Molecule Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) in Patients With Advanced Cancers
- (2008) Alex A. Adjei et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of PAX3 by TGF-β Modulates Melanocyte Viability
- (2008) Guang Yang et al. MOLECULAR CELL
- Pigmentation PAX-ways: the role of Pax3 in melanogenesis, melanocyte stem cell maintenance, and disease
- (2008) Jennifer D. Kubic et al. Pigment Cell & Melanoma Research
- Oncogenic BRAF Regulates Melanoma Proliferation through the Lineage Specific Factor MITF
- (2008) Claudia Wellbrock et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now